Published in Clin J Am Soc Nephrol on November 23, 2011
Potassium urinary excretion and dietary intake: a cross-sectional analysis in 8-10 year-old children. BMC Pediatr (2015) 1.40
Association between usual sodium and potassium intake and blood pressure and hypertension among U.S. adults: NHANES 2005-2010. PLoS One (2013) 1.17
Sodium-to-potassium ratio and blood pressure, hypertension, and related factors. Adv Nutr (2014) 1.01
Potassium and health. Adv Nutr (2013) 0.98
Use of Urine Biomarkers to Assess Sodium Intake: Challenges and Opportunities. Annu Rev Nutr (2015) 0.93
Dietary approaches to prevent hypertension. Curr Hypertens Rep (2013) 0.92
The relationship of dietary sodium, potassium, fruits, and vegetables intake with blood pressure among Korean adults aged 40 and older. Nutr Res Pract (2014) 0.89
Association of urinary sodium-to-potassium ratio with obesity in a multiethnic cohort. Am J Clin Nutr (2014) 0.81
Urinary Potassium Excretion and Renal and Cardiovascular Complications in Patients with Type 2 Diabetes and Normal Renal Function. Clin J Am Soc Nephrol (2015) 0.79
Chemical sensor platform for non-invasive monitoring of activity and dehydration. Sensors (Basel) (2015) 0.78
Four to seven random casual urine specimens are sufficient to estimate 24-h urinary sodium/potassium ratio in individuals with high blood pressure. J Hum Hypertens (2015) 0.77
Time to Consider Use of the Sodium-to-Potassium Ratio for Practical Sodium Reduction and Potassium Increase. Nutrients (2017) 0.77
Potassium Homeostasis: The Knowns, the Unknowns, and the Health Benefits. Physiology (Bethesda) (2017) 0.76
Blood pressure and levels of Fe, Ca, Mg, Zn, Cu, Na and K in the hair of young Bantu men from Tanzania. Biol Trace Elem Res (2013) 0.76
The Effect of the Sodium to Potassium Ratio on Hypertension Prevalence: A Propensity Score Matching Approach. Nutrients (2016) 0.75
Cardiovascular benefits associated with higher dietary K(+) vs. lower dietary Na(+): evidence from population and mechanistic studies. Am J Physiol Endocrinol Metab (2017) 0.75
Urinary stones as a novel matrix for human biomonitoring of toxic and essential elements. Environ Geochem Health (2015) 0.75
Relationship of sodium intake with obesity among Iranian children and adolescents. ARYA Atheroscler (2017) 0.75
A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med (1999) 82.86
Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet (2002) 40.37
Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. N Engl J Med (2001) 20.18
A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. N Engl J Med (1997) 19.93
Impact of high-normal blood pressure on the risk of cardiovascular disease. N Engl J Med (2001) 10.54
The Dallas Heart Study: a population-based probability sample for the multidisciplinary study of ethnic differences in cardiovascular health. Am J Cardiol (2004) 9.43
Sodium and potassium in the pathogenesis of hypertension. N Engl J Med (2007) 5.70
End-stage renal disease in African-American and white men. 16-year MRFIT findings. JAMA (1997) 5.09
Dietary sodium intake and mortality: the National Health and Nutrition Examination Survey (NHANES I). Lancet (1998) 5.02
Implications of small reductions in diastolic blood pressure for primary prevention. Arch Intern Med (1995) 3.71
Effect of potassium-enriched salt on cardiovascular mortality and medical expenses of elderly men. Am J Clin Nutr (2006) 3.38
Elevated blood pressure and risk of end-stage renal disease in subjects without baseline kidney disease. Arch Intern Med (2005) 2.90
Joint effects of sodium and potassium intake on subsequent cardiovascular disease: the Trials of Hypertension Prevention follow-up study. Arch Intern Med (2009) 2.81
Differences in left ventricular structure between black and white hypertensive adults: the Hypertension Genetic Epidemiology Network study. Hypertension (2004) 2.36
Intake of potassium, magnesium, calcium, and fiber and risk of stroke among US men. Circulation (1998) 1.94
Antagonistic regulation of ROMK by long and kidney-specific WNK1 isoforms. Proc Natl Acad Sci U S A (2006) 1.93
Urinary potassium excretion and sodium sensitivity in blacks. Hypertension (2004) 1.79
Normotensive salt sensitivity: effects of race and dietary potassium. Hypertension (1999) 1.74
Increased blood pressure during potassium depletion in normotensive men. N Engl J Med (1989) 1.69
Black-white differences in stroke incidence in a national sample. The contribution of hypertension and diabetes mellitus. JAMA (1990) 1.63
The influence of oral potassium chloride on blood pressure in hypertensive men on a low-sodium diet. N Engl J Med (1990) 1.54
Effects of volume expansion and contraction in normotensive whites, blacks, and subjects of different ages. Circulation (1979) 1.36
Body mass index and associations of sodium and potassium with blood pressure in INTERSALT. Hypertension (1994) 1.24
Feasibility and efficacy of sodium reduction in the Trials of Hypertension Prevention, phase I. Trials of Hypertension Prevention Collaborative Research Group. Hypertension (1993) 1.22
Racial differences in urinary potassium excretion. J Am Soc Nephrol (2008) 1.18
Timed overnight sodium and potassium excretion and blood pressure in steel workers in North China. J Hypertens (1986) 1.14
Relationship of urinary sodium/potassium excretion and calcium intake to blood pressure and prevalence of hypertension among older Chinese vegetarians. Eur J Clin Nutr (2003) 0.99
High sodium chloride diets injure arteries and raise mortality without changing blood pressure. Hypertension (1990) 0.91
The effect of potassium supplementation in persons with a high-normal blood pressure. Results from phase I of the Trials of Hypertension Prevention (TOHP). Trials of Hypertension Prevention (TOHP) Collaborative Research Group. Ann Epidemiol (1995) 0.90
Mechanisms of disease: WNK-ing at the mechanism of salt-sensitive hypertension. Nat Clin Pract Nephrol (2007) 0.89
Effects of age and sex on sodium chloride sensitivity: association with plasma renin activity. Clin Nephrol (1994) 0.89
Combined angiotensin inhibition for the treatment of diabetic nephropathy. N Engl J Med (2013) 7.29
FGF23 induces left ventricular hypertrophy. J Clin Invest (2011) 7.22
Regulation of fibroblast growth factor-23 signaling by klotho. J Biol Chem (2006) 6.50
Klotho deficiency causes vascular calcification in chronic kidney disease. J Am Soc Nephrol (2010) 4.59
Klotho: a novel phosphaturic substance acting as an autocrine enzyme in the renal proximal tubule. FASEB J (2010) 2.91
The metabolic syndrome and uric acid nephrolithiasis: novel features of renal manifestation of insulin resistance. Kidney Int (2004) 2.89
Removal of sialic acid involving Klotho causes cell-surface retention of TRPV5 channel via binding to galectin-1. Proc Natl Acad Sci U S A (2008) 2.62
Klotho deficiency is an early biomarker of renal ischemia-reperfusion injury and its replacement is protective. Kidney Int (2010) 2.50
Uric acid and incident kidney disease in the community. J Am Soc Nephrol (2008) 2.44
Nephrolithiasis-associated bone disease: pathogenesis and treatment options. Kidney Int (2010) 2.35
Isolated C-terminal tail of FGF23 alleviates hypophosphatemia by inhibiting FGF23-FGFR-Klotho complex formation. Proc Natl Acad Sci U S A (2009) 2.23
Association between major depressive episodes in patients with chronic kidney disease and initiation of dialysis, hospitalization, or death. JAMA (2010) 2.16
Low urine pH: a novel feature of the metabolic syndrome. Clin J Am Soc Nephrol (2007) 2.02
The Framingham predictive instrument in chronic kidney disease. J Am Coll Cardiol (2007) 2.00
Hypophosphatemia: an evidence-based approach to its clinical consequences and management. Nat Clin Pract Nephrol (2006) 1.98
Antagonistic regulation of ROMK by long and kidney-specific WNK1 isoforms. Proc Natl Acad Sci U S A (2006) 1.93
DGKE variants cause a glomerular microangiopathy that mimics membranoproliferative GN. J Am Soc Nephrol (2012) 1.93
Vitamin D receptor agonists increase klotho and osteopontin while decreasing aortic calcification in mice with chronic kidney disease fed a high phosphate diet. Kidney Int (2012) 1.82
Prevalence of major depressive episode in CKD. Am J Kidney Dis (2009) 1.79
Pathophysiologic basis for normouricosuric uric acid nephrolithiasis. Kidney Int (2002) 1.78
Fibroblast growth factor 23 and Klotho: physiology and pathophysiology of an endocrine network of mineral metabolism. Annu Rev Physiol (2013) 1.78
Effect of high protein diet on stone-forming propensity and bone loss in rats. Kidney Int (2003) 1.76
WNK1 activates SGK1 to regulate the epithelial sodium channel. Proc Natl Acad Sci U S A (2005) 1.76
Regulation of renal outer medullary potassium channel and renal K(+) excretion by Klotho. Mol Pharmacol (2009) 1.75
Metabolic syndrome and the risk of calcium stones. Nephrol Dial Transplant (2012) 1.71
Intersectin links WNK kinases to endocytosis of ROMK1. J Clin Invest (2007) 1.67
Albumin regulates the Na+/H+ exchanger 3 in OKP cells. J Am Soc Nephrol (2003) 1.67
Urine composition in type 2 diabetes: predisposition to uric acid nephrolithiasis. J Am Soc Nephrol (2006) 1.66
Klotho: a novel regulator of calcium and phosphorus homeostasis. Pflugers Arch (2011) 1.63
What nephrologists need to know about gadolinium. Nat Clin Pract Nephrol (2007) 1.60
Comparison of insulin action on glucose versus potassium uptake in humans. Clin J Am Soc Nephrol (2011) 1.57
Cloning and characterization of the human soluble adenylyl cyclase. Am J Physiol Cell Physiol (2005) 1.54
Hypercalciuria associated with high dietary protein intake is not due to acid load. J Clin Endocrinol Metab (2011) 1.54
The relationship between nontraditional risk factors and outcomes in individuals with stage 3 to 4 CKD. Am J Kidney Dis (2008) 1.53
Circadian variation in urine pH and uric acid nephrolithiasis risk. Nephrol Dial Transplant (2007) 1.51
Etiological role of estrogen status in renal stone formation. J Urol (2002) 1.48
Long-term combined treatment with thiazide and potassium citrate in nephrolithiasis does not lead to hypokalemia or hypochloremic metabolic alkalosis. Kidney Int (2003) 1.46
Defining hypercalciuria in nephrolithiasis. Kidney Int (2011) 1.44
Uromodulin upregulates TRPV5 by impairing caveolin-mediated endocytosis. Kidney Int (2013) 1.44
Validation of depression screening scales in patients with CKD. Am J Kidney Dis (2009) 1.43
Pilot trial of cryoplasty or conventional balloon post-dilation of nitinol stents for revascularization of peripheral arterial segments: the COBRA trial. J Am Coll Cardiol (2012) 1.43
Predictors of hyperkalemia and death in patients with cardiac and renal disease. Am J Cardiol (2012) 1.42
Metabolic basis for low urine pH in type 2 diabetes. Clin J Am Soc Nephrol (2010) 1.41
Role of inflammation in diabetic nephropathy. Curr Diabetes Rev (2008) 1.41
Renal ammonium excretion after an acute acid load: blunted response in uric acid stone formers but not in patients with type 2 diabetes. Am J Physiol Renal Physiol (2013) 1.40
Evidence for endocytosis of ROMK potassium channel via clathrin-coated vesicles. Am J Physiol Renal Physiol (2002) 1.39
WNK1 activates SGK1 by a phosphatidylinositol 3-kinase-dependent and non-catalytic mechanism. J Biol Chem (2005) 1.37
PIP2 activates TRPV5 and releases its inhibition by intracellular Mg2+. J Gen Physiol (2005) 1.35
Conformational changes of pore helix coupled to gating of TRPV5 by protons. EMBO J (2005) 1.31
Glucocorticoids acutely increase cell surface Na+/H+ exchanger-3 (NHE3) by activation of NHE3 exocytosis. Am J Physiol Renal Physiol (2005) 1.31
Mechanism and molecular determinant for regulation of rabbit transient receptor potential type 5 (TRPV5) channel by extracellular pH. J Biol Chem (2003) 1.27
Effect of renal lipid accumulation on proximal tubule Na+/H+ exchange and ammonium secretion. Am J Physiol Renal Physiol (2008) 1.27
The erythropoietin receptor is a downstream effector of Klotho-induced cytoprotection. Kidney Int (2013) 1.27
Protein kinase C inhibits caveolae-mediated endocytosis of TRPV5. Am J Physiol Renal Physiol (2008) 1.27
Renal transport of uric acid: evolving concepts and uncertainties. Adv Chronic Kidney Dis (2012) 1.26
Cardioprotection by Klotho through downregulation of TRPC6 channels in the mouse heart. Nat Commun (2012) 1.25
Lipid- and mechanosensitivities of sodium/hydrogen exchangers analyzed by electrical methods. Proc Natl Acad Sci U S A (2004) 1.23
Luminal Na(+)/H (+) exchange in the proximal tubule. Pflugers Arch (2008) 1.21
Insulin activates Na(+)/H(+) exchanger 3: biphasic response and glucocorticoid dependence. Am J Physiol Renal Physiol (2002) 1.20
Novel insights into the pathogenesis of uric acid nephrolithiasis. Curr Opin Nephrol Hypertens (2004) 1.20
Biochemical and stone-risk profiles with topiramate treatment. Am J Kidney Dis (2006) 1.19
IRBIT governs epithelial secretion in mice by antagonizing the WNK/SPAK kinase pathway. J Clin Invest (2011) 1.18
Monitoring protein-protein interactions between the mammalian integral membrane transporters and PDZ-interacting partners using a modified split-ubiquitin membrane yeast two-hybrid system. Mol Cell Proteomics (2008) 1.18
Rapid Communication: relative effect of urinary calcium and oxalate on saturation of calcium oxalate. Kidney Int (2004) 1.18
Regulation of ROMK channel and K+ homeostasis by kidney-specific WNK1 kinase. J Biol Chem (2009) 1.17
Dietary potassium restriction stimulates endocytosis of ROMK channel in rat cortical collecting duct. Am J Physiol Renal Physiol (2003) 1.14
Protein kinase C inhibits ROMK1 channel activity via a phosphatidylinositol 4,5-bisphosphate-dependent mechanism. J Biol Chem (2003) 1.14
Secreted klotho and chronic kidney disease. Adv Exp Med Biol (2012) 1.13
Role of c-SRC and ERK in acid-induced activation of NHE3. Kidney Int (2002) 1.13
Endothelial-specific expression of WNK1 kinase is essential for angiogenesis and heart development in mice. Am J Pathol (2009) 1.12
Nephrolithiasis in children. Pediatr Nephrol (2005) 1.12
Activation of dopamine D1-like receptors induces acute internalization of the renal Na+/phosphate cotransporter NaPi-IIa in mouse kidney and OK cells. Am J Physiol Renal Physiol (2004) 1.11
Dopamine acutely decreases apical membrane Na/H exchanger NHE3 protein in mouse renal proximal tubule. Kidney Int (2003) 1.11
Klotho and chronic kidney disease. Contrib Nephrol (2013) 1.11
Role of with-no-lysine [K] kinases in the pathogenesis of Gordon's syndrome. Pediatr Nephrol (2006) 1.11
Ontogeny of NHE8 in the rat proximal tubule. Am J Physiol Renal Physiol (2007) 1.10
Adiponectin promotes functional recovery after podocyte ablation. J Am Soc Nephrol (2013) 1.09
Rhabdomyolysis: a review, with emphasis on the pediatric population. Pediatr Nephrol (2010) 1.08
The emerging role of Klotho in clinical nephrology. Nephrol Dial Transplant (2012) 1.08
A sperm-specific Na+/H+ exchanger (sNHE) is critical for expression and in vivo bicarbonate regulation of the soluble adenylyl cyclase (sAC). Proc Natl Acad Sci U S A (2007) 1.08
Unfractionated heparin for hemodialysis: still the best option. Semin Dial (2010) 1.07
Steady-state function of the ubiquitous mammalian Na/H exchanger (NHE1) in relation to dimer coupling models with 2Na/2H stoichiometry. J Gen Physiol (2008) 1.07
Reduction of renal triglyceride accumulation: effects on proximal tubule Na+/H+ exchange and urinary acidification. Am J Physiol Renal Physiol (2009) 1.07
Na+/H+ exchangers in renal regulation of acid-base balance. Semin Nephrol (2006) 1.06
Klotho as a potential biomarker and therapy for acute kidney injury. Nat Rev Nephrol (2012) 1.06
Activation of PI3-kinase stimulates endocytosis of ROMK via Akt1/SGK1-dependent phosphorylation of WNK1. J Am Soc Nephrol (2011) 1.05
Na+/H+ exchangers: physiology and link to hypertension and organ ischemia. Curr Opin Nephrol Hypertens (2005) 1.05
Characterization of the regulation of renal Na+/H+ exchanger NHE3 by insulin. Am J Physiol Renal Physiol (2006) 1.04
Renal and extrarenal actions of Klotho. Semin Nephrol (2013) 1.04
Structural determinants and specificities for ROMK1-phosphoinositide interaction. Am J Physiol Renal Physiol (2002) 1.02
Characterization of the sodium/hydrogen exchanger NHA2. J Am Soc Nephrol (2008) 1.02
Nephrogenic systemic fibrosis risk: is there a difference between gadolinium-based contrast agents? Semin Dial (2008) 1.02
Nephrolithiasis in topiramate users. Urol Res (2010) 1.01
Shank2 associates with and regulates Na+/H+ exchanger 3. J Biol Chem (2005) 1.01
Acute regulation of Na/H exchanger NHE3 by adenosine A(1) receptors is mediated by calcineurin homologous protein. J Biol Chem (2003) 1.00
Postpneumonectomy lung expansion elicits hypoxia-inducible factor-1alpha signaling. Am J Physiol Lung Cell Mol Physiol (2007) 1.00
Characterization of Na+/H+ exchanger NHE8 in cultured renal epithelial cells. Am J Physiol Renal Physiol (2007) 1.00
Identification and functional characterization of Kir2.6 mutations associated with non-familial hypokalemic periodic paralysis. J Biol Chem (2011) 1.00
Calcium-sensing receptor decreases cell surface expression of the inwardly rectifying K+ channel Kir4.1. J Biol Chem (2010) 0.99
Serum and glucocorticoid-induced kinase (SGK) 1 and the epithelial sodium channel are regulated by multiple with no lysine (WNK) family members. J Biol Chem (2010) 0.99